NCT03089970View on ClinicalTrials.gov

Using Breath Metabolites to Determine Specific Virus Infection in Asthmatic Patients

CompletedOBSERVATIONAL
Enrollment

19

Participants

Timeline

Start Date

February 1, 2017

Primary Completion Date

March 10, 2020

Study Completion Date

September 1, 2020

Conditions
Upper Respiratory Tract Infections, Asthma, Exhaled Breath
Interventions
DIAGNOSTIC_TEST

Exhaled breath condensate collection

Breath from humans is cooled, condensed, and collected

Trial Locations (1)

96817

University of California Davis Medical Ceneter, Sacramento

All Listed Sponsors
collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

lead

University of California, Davis

OTHER

NCT03089970 - Using Breath Metabolites to Determine Specific Virus Infection in Asthmatic Patients | Biotech Hunter | Biotech Hunter